This message was sent to ##Email##
|
|
|
HealthDay via U.S. News & World Report
The human papillomavirus vaccine appears to prevent abnormalities that can lead to cervical cancer, a new study shows. Canadian researchers found that young women who received the vaccine through a school-based program were less likely to have such abnormalities when screened for cervical cancer than those who did not receive the vaccine. The young women were screened less than 10 years after they received their first HPV vaccine.
READ MORE
American College of Surgeons
In a new Journal of the American College of Surgeons study, 92 percent of the colorectal polyps in patients referred for operations were noncancerous, suggesting advanced endoscopic treatments may be a viable option.
For the majority of patients with large or difficult to remove colorectal polyps (growths in the colon), the incidence of cancer is actually lower than previously thought, and using more advanced endoscopic techniques that spare the colon may be a better, safer alternative to a traditional operation in certain cases, according to study results published online in the Journal of the American College of Surgeons in advance of print publication.
READ MORE
AJCC
The AJCC announces five disease site webinars that are scheduled for summer and early fall this year. The webinars, provided at no cost, will provide highlights of the five most common site chapters for AJCC 7th edition staging and include: Melanoma, Lung, Breast, Colorectum and Prostate. There will be pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
Each lecture will contain the following topics:
Overview and Learning Objectives
Anatomy Affecting Stage
Classification Issues
Assigning T, N, M, Stage Group
Information and Questions on AJCC Staging and Summary
The first live webinar (Melanoma) will occur on July 27. Register now. This webinar will be recorded for anyone who is not able to attend the live session.
You can visit the AJCC website to learn more about the Disease Site webinars and stay informed.
Promoted by
|
|
|
 |
Cancer Therapy Advisor
The American Society for Clinical Oncology has issued new clinical practice guidelines for invasive cervical cancer. The guidelines are the first to be "resource-stratified," meaning that they provide specific recommendations based on the availability of health care in different regions.
READ MORE
Tech Times
An existing drug used to treat leukemia shows promise in helping fight a specific type of ovarian cancer, a new study has found. In a mice study, researchers discovered that the growth of ovarian cancer cells stopped when they gave the subjects a drug treatment using dasatinib. The researchers noted that the drug seems to target a defective gene found in specific ovarian cancer tumors.
READ MORE
|
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
Tech Times
A scientist from the University of Texas San Antonio has developed a novel way of killing cancer cells using ultraviolet light. The new method can potentially help cancer patients with hard-to-reach or inoperable malignant tumors, especially young children.
READ MORE
Cancer Therapy Advisor via Endocrinology Advisor
There were no effective therapeutic options for advanced thyroid cancer until 5 years ago, a presenter said at the 2016 American Society of Oncology Annual Meeting. "Our understanding of the molecular basis of thyroid carcinogenesis improved, and clinical trials developed based on in vitro data demonstrated that kinase inhibitors interfered with thyroid cancer cell growth," Ann W. Gramza, MD, medical oncologist at the MedStar Georgetown Lombardi Comprehensive Cancer Center in Washington, DC, explained during a poster discussion session.
READ MORE
|
SPONSORED CONTENT | Advertisement
|
Promoted by
|
|
|
 |
Cancer Network
Both African-American and Caucasian patients with advanced renal cell carcinoma have seen improved survival since the advent of targeted therapies, according to a new analysis. Though African-American patients still have a survival disadvantage compared with Caucasians, this finding suggests that targeted therapies have benefitted both groups similarly.
READ MORE
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
Oncology Nurse Advisor
Cancer is a pandemic. Given new advances in cancer detection, increased screening and a growing aged population, the next 20 years will see a significant increase in cancer diagnoses, effecting approximately 70 percent of the world's population. Moreover, cancer does not discriminate, often affecting vulnerable populations.
READ MORE
The Washington Post
Women with a mutation in the BRCA1 gene, which is already linked to breast and ovarian cancers, also face a higher risk of a deadly type of uterine cancer, according to a new study. Lead author Noah Kauff, director of Clinical Cancer Genetics at the Duke Cancer Institute, said the study was the first "conclusive link" between the gene defect and an increased likelihood of serous endometrial carcinoma, a type of cancer that affects the lining of the uterus and has a mortality rate of 50 percent.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|